Norifumi Iseda

8PUBLICATIONS
18CO-AUTHORS
Metabolic medicinePredictive and prognostic markersHaematological tumoursMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 02, 2026
Mac-2 Binding Protein Glycosylation Isomer (M2BPGi)-Based Risk Stratification Refined by Tumor Metabolic Activity in Hepatocellular Carcinoma.

|Aug 28, 2026
Nuclear Pan-Lysine Lactylation Immunoreactivity Is Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma.

|May 18, 2026
Comparison of Anatomical and Non-Anatomical Resection in Low Microvascular Invasion Risk Solitary Hepatocellular Carcinoma ≤ 5 cm.

|Jan 22, 2024
Development of predictive score for postoperative dysphagia after emergency abdominal surgery in patients of advanced age.

Tomohiro Iguchi, Junya Mita, Norifumi Iseda

|Oct 23, 2021
Impact of Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status.

Norifumi Iseda, Shinji Itoh, Tomoharu Yoshizumi

|Jul 19, 2021
Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation.

Shinji Itoh, Tomoharu Yoshizumi, Yoshiyuki Kitamura

Pageof 2

Frequent Collaborators

7 joint publications

Shinji Itoh

5 joint publications

Takeo Toshima

3 joint publications

Kyohei Yugawa

3 joint publications

Tomoharu Yoshizumi